What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Pharmacology
- Diabetes mellitus
T. M. Speight focuses on Pharmacology, Pharmacotherapy, Anesthesia, Analgesic and Dermatology.
His Pharmacology study incorporates themes from Antidepressant and Blood pressure.
His biological study spans a wide range of topics, including Adverse effect, Maintenance therapy, Pharmacology toxicology and Thioridazine.
His Anesthesia research is multidisciplinary, relying on both Clinical trial and Atenolol.
His work on Pethidine and Pentazocine is typically connected to Naproxen as part of general Analgesic study, connecting several disciplines of science.
His study in the fields of Histoplasmosis, Dermatophyte and Griseofulvin under the domain of Dermatology overlaps with other disciplines such as Econazole.
His most cited work include:
- Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy (409 citations)
- Buprenorphine: a review of its pharmacological properties and therapeutic efficacy. (357 citations)
- Mianserin: A Review of its Pharmacological Properties and Therapeutic Efficacy in Depressive Illness (327 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Pharmacology, Pharmacotherapy, Anesthesia, Internal medicine and Dermatology.
T. M. Speight interconnects Intestinal absorption, Asthma and Arthritis in the investigation of issues within Pharmacology.
The Pharmacotherapy study which covers Pharmacology toxicology that intersects with Relative efficacy.
Many of his research projects under Anesthesia are closely connected to Placebo with Placebo, tying the diverse disciplines of science together.
His Internal medicine research incorporates elements of Gastroenterology, Endocrinology, Metronidazole and Cardiology.
His Psoriasis and Acne study in the realm of Dermatology interacts with subjects such as Econazole and Mucocutaneous zone.
He most often published in these fields:
- Pharmacology (61.74%)
- Pharmacotherapy (35.65%)
- Anesthesia (23.48%)
What were the highlights of his more recent work (between 1983-2011)?
- Pharmacology (61.74%)
- Side effect (6.09%)
- Internal medicine (18.26%)
In recent papers he was focusing on the following fields of study:
His primary areas of investigation include Pharmacology, Side effect, Internal medicine, Oral administration and Intestinal absorption.
The Pharmacology study combines topics in areas such as Vascular resistance and Arthritis.
His Side effect research is multidisciplinary, incorporating elements of Erythema, Psoriasis, Rosacea, Acne and Dermatology.
His research integrates issues of Endocrinology and Cardiology in his study of Internal medicine.
In his work, Toxicity and Cholesterol is strongly intertwined with Gastroenterology, which is a subfield of Oral administration.
He usually deals with Intestinal absorption and limits it to topics linked to Food allergy and Asthma.
Between 1983 and 2011, his most popular works were:
- Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy. (238 citations)
- Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. (190 citations)
- Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy (130 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Pharmacology
- Diabetes mellitus
T. M. Speight focuses on Side effect, Anticholinergic, Migraine, Vascular disease and Placebo.
His Anticholinergic study is concerned with the larger field of Pharmacology.
T. M. Speight has included themes like Cinnarizine and Clinical trial in his Migraine study.
As part of his studies on Receptor antagonist, he often connects relevant subjects like Intestinal absorption.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
